Literature DB >> 32633603

Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD.

Amy Kunchok1, Eoin P Flanagan1, Melissa Snyder2, Ruba Saadeh1, John J Chen3, Brian G Weinshenker4, Andrew McKeon1, Sean J Pittock1.   

Abstract

Aquaporin-4 (AQP4) neuromyelitis optica spectrum disorder (NMOSD) has been demonstrated to be associated with non-organ and organ-specific autoantibodies (antinuclear antibody, extractable nuclear antibody, double-stranded DNA, muscle acetylcholine receptor antibody) and systemic autoimmune diseases. In this study, we evaluated whether a similar association with non-organ and organ-specifc autoantibodies occurs in patients with MOG-IgG1-associated disorders. We determined that MOG-IgG1 was not strongly associated with these organ and non-organ-specific autoantibodies. Systemic lupus erythematous (SLE) was significantly associated with AQP4-IgG+ NMOSD and not with MOGAD (p = 0.037). These findings suggest differences in co-existing systemic and organ-specific autoimmunity between MOGAD and AQP4-IgG+ NMOSD.

Entities:  

Keywords:  AQP4-IgG neuromyelitis optica spectrum disorder; MOG-IgG-associated disorders; autoimmunity; humoral immunity; systemic lupus erythematous

Year:  2020        PMID: 32633603     DOI: 10.1177/1352458520933884

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  6 in total

Review 1.  Myelin Oligodendrocyte Glycoprotein-Associated Disorders.

Authors:  Erin Longbrake
Journal:  Continuum (Minneap Minn)       Date:  2022-08-01

Review 2.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.

Authors:  Elia Sechi; Laura Cacciaguerra; John J Chen; Sara Mariotto; Giulia Fadda; Alessandro Dinoto; A Sebastian Lopez-Chiriboga; Sean J Pittock; Eoin P Flanagan
Journal:  Front Neurol       Date:  2022-06-17       Impact factor: 4.086

3.  Recurrent Optic Perineuritis With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Complicated With Granulomatous Polyangiitis.

Authors:  Ken Nagahata; Shotaro Suzuki; Ritsuko Yokochi; Yuichiro Nei; Noboru Hagino
Journal:  Cureus       Date:  2022-05-23

Review 4.  Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD).

Authors:  Yunjie Li; Xia Liu; Jingxuan Wang; Chao Pan; Zhouping Tang
Journal:  Front Aging Neurosci       Date:  2022-03-15       Impact factor: 5.750

5.  Clinical Profile and Treatment Outcome in MOGAD: A Single-Center Case-Series Study in Guiyang, China.

Authors:  Xiaoyang Lei; Shipeng Guo; Shengnan Cui; Yin Pu; Anni Zhang; Dian He
Journal:  Front Neurol       Date:  2022-04-06       Impact factor: 4.086

6.  Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort.

Authors:  Solène Dauby; Dominique Dive; Laurence Lutteri; Cécile Andris; Isabelle Hansen; Pierre Maquet; Emilie Lommers
Journal:  Acta Neurol Belg       Date:  2021-06-07       Impact factor: 2.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.